Queens Hospital, which is part of Barking, Havering and Redbridge University Hospitals NHS Trust, has ordered a DrugLog® system. The system will mainly be used to control preparations of insulin.
Barking, Havering and Redbridge University Hospitals NHS Trust operates two hospitals: King George Hospital and Queens Hospital. Queens Hospital, located in Romsford outside London, has, after extensive testing, chosen to use DrugLog® to control pre-mixed insulin solutions. The hospital pharmacy at Queens prepares a large number of insulin preparations of a certain concentration every day. DrugLog is used as a final step in the production process to ensure that the prepared infusion bag contains the right drug at the right concentration. The order amounts to approximately SEK 300,000 and delivery will take place within the second quarter.
Mats Högberg, CEO, comments: “We are very pleased that Queens are choosing to use DrugLog® to quality assure their insulin preparations. It has been a long evaluation process, but this opens a new application area for DrugLog®. Many hospital pharmacies make ready-made batches of the pre-diluted drug. Until now, they have been referred to control their preparations by HPLC, a complicated and costly method. With DrugLog, they now get a fast and cost-efficient tool to ensure that the patient gets the right drug at the right concentration.”
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on May 14, 2020 at 11:30.
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
Download as PDF